McCarthy Tétrault LLP advised IMV on the offering. On December 20, 2022, IMV Inc., closed its previously announced registered direct offering for total gross proceed of...
IMV’s $9 Million Offering
Medicenna Therapeutics Corp.’s $20 Million Capital Raise
McCarthy Tétrault advised Medicenna Therapeutics Corp. on the matter. On August 11, 2022, Medicenna Therapeutics Corp. closed its previously announced marketed underwritten public offering of units in Canada and in the United States for an...
Iceberg Finance’s Acquisition of iFinance Canada
McCarthy Tétrault assisted the shareholders of Iceberg Finance Inc. on the acquisition. On April 6, 2022, Iceberg Finance Inc. acquired all shares that are in circulation...
Recorrido.cl’s Merger with Busbud Inc.
Bofill Mir Abogados, McCarthy Tetrault and Apparcel Uriarte & Vassallo advised Recorrido.cl on the transaction. Deloitte and Fasken advised Busbud inc. The Canadian travel tech startup Busbud executed...
Optel Vision Inc.’s Acquisition of Pharma Track-and-Trace Business from Körber
McCarthy Tétrault LLP advised Optel Vision on the acquisition. Optel Group, a world leader in supply chain traceability, has acquired the track-and-trace unit of the Körber Business Area...
Appili Therapeutics’ C$7 Million Rights Offering
McCarthy Tétrault advised the syndicate of agents in connection with Appili Therapeutics’ offering. Appili Therapeutics Inc. closed its previously announced public offering of units. Pursuant to the Offering,...
CIB and Fiera Private Debt’s C$160 Million Investment in SOFIAC
McCarthy Tétrault LLP represented Société de financement et d’accompagnement en performance énergétique s.e.c. (SOFIAC) on the transaction. On September 15, 2021, the Société de financement et...
IMV Inc.’s $25 Million Public Offering
McCarthy Tétrault advised IMV in connection with the offering. On July 20, 2021, IMV Inc. closed an underwritten public offering of 14,285,714 units, for total gross...
IntelGenx’s Strategic Partnership with atai Life Sciences
Torys LLP represented atai on the deal. McCarthy Tetrault LLP assisted IntelGenx . On May 14, 2021, IntelGenx Technologies Corp. (“IntelGenx”), a leader in pharmaceutical films completed...